– UK, Cambridge – Lightcast, a pioneering life science tools company, announced the appointment of Philip Binns as chairman of its board of directors, effective May 1, 2025, bringing decades of experience in scientific instrumentation and leadership, recently serving as president of the life sciences and applied markets group at Agilent Technologies.
About Philip Binns
Philip Binns joined Agilent in 2010 through its acquisition of Varian, Inc., where he played a pivotal role in expanding the company’s atomic and molecular spectroscopy portfolio into a market-leading business.
In addition to his new role at Lightcast, Philip Binns serves as chair and non-executive director of Epiminder, a company developing implantable brain-monitoring devices; as a director of the Bionics Institute, a globally recognized medical device research organization; and as a National Council Advisor to the Australian Industry AI Group.
“The Lightcast Envisia™ platform has the potential to transform single-cell analysis by unlocking functional insights that were previously out of reach,” said Philip Binns. “The company is at an exciting inflection point, and I’m eager to collaborate with this talented team to support the platform’s global adoption and help drive the next generation of biologics and therapies.”
Philip Binns holds a degree in business management from the University of Melbourne and an MBA from Melbourne Business School.
About Lightcast
Lightcast aims to unleash new capabilities within the single-cell analysis field by developing a more accessible, scalable, and flexible platform for scientists in basic, translational, and applied research. These capabilities will empower new biological discoveries and accelerate the development of novel drugs, therapies, and biologics. Founded in 2019 and based in Cambridge, UK, Lightcast has invented a technology that uses rays of light to control picoliter-scale droplets for functional analysis of individual cells.
For more information: https://www.lightcast.bio/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.